We are live on ! Find out more
CKPT

Checkpoint Therapeutics
CKPT

Delisted

CKPT was delisted on the 29th of May, 2025.

Back to rankings

57 hedge funds and large institutions have $12.6M invested in Checkpoint Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more capital invested

Capital invested by funds: $10.3M → $12.6M (+$2.34M)

0.14% more ownership

Funds ownership: 1.19% → 1.33% (+0.14%)

8% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 13

8% less funds holding

Funds holding: 62 → 57 (-5)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

57% less call options, than puts

Call options by funds: $411K | Put options by funds: $957K

Holders
57
Holders Change
-5
Holders Change %
-8.06%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
12
Reduced
13
Closed
9
Calls
$411K
Puts
$957K
Net Calls
-$546K
Net Calls Change
-$889K

Top Buyers

Rank Fund Capital Flow
1
JSMC
Jess S. Morgan & Co
California
+$902K
2
GCP
GSA Capital Partners
United Kingdom
+$341K
3
BBA
Baader Bank Aktiengesellschaft
Germany
+$105K
4
AI
Atom Investors
Texas
+$81.9K
5
BRWA
B. Riley Wealth Advisors
Florida
+$64.3K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$473K
2
Millennium Management
Millennium Management
New York
-$343K
3
Two Sigma Investments
Two Sigma Investments
New York
-$88.5K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$84.5K
5
Simplex Trading
Simplex Trading
Illinois
-$60.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$61K -$50.5K -4,240 -42%
BC
27
Bartlett & Co
Ohio
$52K – – –
BCWM
28
Bartlett & Co Wealth Management
Ohio
$52K – – –
Two Sigma Investments
29
Two Sigma Investments
New York
$48K -$88.5K -7,426 -62%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$44K – – –
Charles Schwab
31
Charles Schwab
California
$36K – – –
UBS Group
32
UBS Group
Switzerland
$32K +$10.8K +903 +42%
Morgan Stanley
33
Morgan Stanley
New York
$28K -$4.29K -360 -12%
OAM
34
Occidental Asset Management
California
$27K – – –
SBH
35
Segall Bryant & Hamill
Illinois
$26K – – –
JF
36
Joule Financial
Kentucky
$20K – – –
FIM
37
Freedom Investment Management
Connecticut
$18.6K -$834 -70 -4%
Citadel Advisors
38
Citadel Advisors
Florida
$17K -$50.8K -4,267 -72%
FAIM
39
Financial Advocates Investment Management
Washington
$16K – – –
Truist Financial
40
Truist Financial
North Carolina
$15K – – –
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$14K -$4.29K -360 -22%
Commonwealth Equity Services
42
Commonwealth Equity Services
Massachusetts
$14K – – –
AW
43
ACG Wealth
Georgia
$12K – – –
D.E. Shaw & Co
44
D.E. Shaw & Co
New York
$11K – – –
Bank of America
45
Bank of America
North Carolina
$10K – – –
BWCS
46
Beirne Wealth Consulting Services
Connecticut
$10K – – –
LFAS
47
Level Four Advisory Services
Texas
$10K – – –
TWM
48
Tradition Wealth Management
Minnesota
$7K – – –
TRCT
49
Tower Research Capital (TRC)
New York
$5K -$2.47K -207 -32%
Rockefeller Capital Management
50
Rockefeller Capital Management
New York
$5K – – –
1
2
3

CKPT Hedge Fund Activity: Q3 2022 in Review

57 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q3 2022, worth a combined $12.6M — up 23% from $10.3M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of CKPT and 5 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 12 added.

The largest buyer was Jess S. Morgan & Co, adding an estimated $902K. The largest seller was Renaissance Technologies, cutting an estimated $473K.

  • 57 institutional investors held Checkpoint Therapeutics (CKPT) as of Q3 2022, down from 62 in Q2 2022.
  • Funds reported $12.6M of Checkpoint Therapeutics stock for Q3 2022, up 23% quarter-over-quarter.
  • 5 funds opened new Checkpoint Therapeutics positions in Q3 2022 and 9 closed out, a net change of -4 holders.
  • The largest Checkpoint Therapeutics buyer in Q3 2022 was Jess S. Morgan & Co, an estimated $902K added.
  • The largest Checkpoint Therapeutics seller in Q3 2022 was Renaissance Technologies, an estimated $473K sold.

Based on aggregated 13F filings for Q3 2022.